Cancel

Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies

Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ...
i3 Health

New Data and Emerging Management Strategies for Migraine Headache

STATEMENT OF NEED Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i...
i3 Health

Podcast: New Data and Emerging Management Strategies for Migraine Headache

STATEMENT OF NEED Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i...
i3 Health

Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: AN EXPERT-LED EXPLORATION OF RECENT AND EMERGING TRIAL DATA AND CURRENT GUIDELINE RECOMMENDATIONS

Designed and developed to maximize digital audience reach and engagement, this Medical Moments webinar will review all clinically relevant aspects of cancer-related anemia (CRA) management, including chemotherapy-induced anemia (CIA). The activity will begin with a brief primer on iron metabolism and absorption principles, including the practical distinctions between absolute and functional iron deficiency, and the impact of that distinction on treatment approaches. An appraisal of the foundat...
CE Concepts

Therapy of B-Cell Acute Lymphoblastic Leukemia: An Evolving Landscape

Presented by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School, this activity will highlight individualized treatment selection for patients with acute lymphoblastic leukemia (ALL), as well as recent efficacy and safety data for novel therapeutic strategies. Start the activity now. STATEMENT OF NEED Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the proliferation of immature lymphoid cells throughout the bone marrow and blood (Rana...
i3 Health

Improving Outcomes in Hodgkin Lymphoma

This in-depth discussion, presented by Louis Diehl, MD, Professor of Medicine at Duke University Medical School, will feature strategies for incorporating predictive and prognostic markers, recent efficacy and safety data, and adverse event management strategies into treatment selection for patients with Hodgkin lymphoma (HL). Start the activity now. STATEMENT OF NEED Hodgkin lymphoma (HL) is a rare malignancy of the lymph nodes and lymphatic system, with about 8,830 new cases diagnosed ...
i3 Health

Updates in Myelodysplastic Syndromes: Improving Patient Outcomes

This activity, presented by Mikkael Sekeres, MD, Chief of the Division of Hematology at the University of Miami Health System, will focus on predictive and prognostic markers for myelodysplastic syndromes (MDS), emerging data on novel therapies, and strategies to optimize safety and tolerability for patients with this disease. Start the activity now. STATEMENT OF NEED Myelodysplastic syndromes (MDS) comprise a heterogeneous group ofmyeloid malignanciesthat derive from abnormal multipot...
i3 Health

Key Considerations in Managing Atopic Dermatitis in Black Patients

Statement of Need Atopic dermatitis (AD), a severe form of eczema and intense pruritus, is associated with a substantial and multifaceted patient-reported burden that encompasses sleep disturbances, anxiety, depression, reduced function/productivity, and impaired quality of life. The incidence of AD is high, estimated to be approximately 15%-20% in children and 1%-3% in adults worldwide (Yong & Tay, 2017). Population studies within the United States have shown that AD disproportionately...
i3 Health

Facts on COVID-19 Vaccinations: Pfizer BioNTech

Pharmacists and other health professionals can play crucial roles in administering and advocating for vaccination, especially during the pandemic. Learners’ knowledge should stay up-to-date in order to serve the population and aid in efforts to gaining herd immunity with vaccinations.
SIUE School of Pharmacy

Expanding Cultural Competencies for Transgender and Transitioning Patients

Pharmacists lack the cultural competency training and pharmacological care in the transgender community. This course is designed to increase awareness of the importance of transgender need in healthcare and to help pharmacists increase culturally competent in treating transitioning patients, including communication strategies.
SIUE School of Pharmacy

Sexual Harassment for Pharmacists - 2022 Update

Illinois law requires that health providers with professional licenses issued by the Illinois Department of Financial and Professional Regulation (IDFPR ) that require CE credits for renewal must complete 1 hour of CE on the topic of sexual harassment prevention training per licensure period. Sexual harassment is a continuing concern in the workplace. Pharmacists should be knowledgeable enough to recognize sexual harassment, including the different types and what to do when they encoun...
SIUE School of Pharmacy

Strategies for PD-L1 Testing and Targeted Therapy With Immune Checkpoint Inhibitors for NSCLC

Target Audience Oncology physicians, nurse practitioners, physician assistants; pulmonary physicians, nurse practitioners, physician assistants; pathologists and pharmacists. Program Overview Despite advances in the treatment of non-small cell lung cancer (NSCLC), overall 5-year survival has not significantly improved in recent years. Newly approved and emerging immune checkpoint inhibitor (ICI) therapies offer improvements in survival over chemotherapy alone, but toxicities and immune-re...
Rutgers Biomedical and Health Sciences and Spire Learning

PD-L1 Testing for NSCLC

Target Audience Oncology physicians, nurse practitioners, physician assistants; pulmonary physicians, nurse practitioners, physician assistants; pathologists and pharmacists. Program Overview Despite advances in the treatment of non-small cell lung cancer (NSCLC), overall 5-year survival has not significantly improved in recent years. Newly approved and emerging immune checkpoint inhibitor (ICI) therapies offer improvements in survival over chemotherapy alone, but toxicities and immune-re...
Rutgers Biomedical and Health Sciences and Spire Learning

Clinical Efficacy of Current Available and Investigational ICIS for NSCLC

Target Audience Oncology physicians, nurse practitioners, physician assistants; pulmonary physicians, nurse practitioners, physician assistants; pathologists and pharmacists. Program Overview Despite advances in the treatment of non-small cell lung cancer (NSCLC), overall 5-year survival has not significantly improved in recent years. Newly approved and emerging immune checkpoint inhibitor (ICI) therapies offer improvements in survival over chemotherapy alone, but toxicities and immune-re...
Rutgers Biomedical and Health Sciences and Spire Learning

Clinical Safety of Current Available and Investigational ICIS for NSCLC

Target Audience Oncology physicians, nurse practitioners, physician assistants; pulmonary physicians, nurse practitioners, physician assistants; pathologists and pharmacists. Program Overview Despite advances in the treatment of non-small cell lung cancer (NSCLC), overall 5-year survival has not significantly improved in recent years. Newly approved and emerging immune checkpoint inhibitor (ICI) therapies offer improvements in survival over chemotherapy alone, but toxicities and immune-re...
Rutgers Biomedical and Health Sciences and Spire Learning

WEBINAR: Ethical and Practical Compliance

Pharmacists are responsible for many tasks, including the compliance requirements for the pharmacy. Knowledge of the regulations and insurance requirements is critical for patient safety and to keep the pharmacy out of trouble! This program will review the consequences of past unethical behavior, provide an overview of main compliance requirements, and resources to maintain compliance standards. This is a knowledge-based CE activity and is targeted to pharmacists and technicians.  ...
Pharmacists Public Health Initiatives

Medication Safety Update: Preventing Errors and Adverse Drug Reactions - Florida Board Approved

The “Oath of a Pharmacist” that is recited at pharmacy school graduations emphasizes the importance of medication safety in the profession. The passage says, “I will apply my knowledge, experience, and skills to the best of my ability to assure optimal outcomes for my patients.” Despite these efforts, preventable adverse events related to medications do occur, and all health care professionals can play an integral role in reducing them. Health care professionals need a broad understand...
The Rx Consultant

Medication Safety Update: Preventing Errors and Adverse Drug Reactions - Florida Board Approved

The “Oath of a Pharmacist” that is recited at pharmacy school graduations emphasizes the importance of medication safety in the profession. The passage says, “I will apply my knowledge, experience, and skills to the best of my ability to assure optimal outcomes for my patients.” Despite these efforts, preventable adverse events related to medications do occur, and all health care professionals can play an integral role in reducing them. Health care professionals need a broad understand...
The Rx Consultant

New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy

Join our Expert Faculty, Drs. Joel W. Neal, MD, PhD and Victoria Sherry, DNP, CRNP, AOCNP as they discuss treatment principles across the continuum of care in unresectable, stage III NSCLC. During their presentations and discussion, they will examine the established treatment landscape for unresectable, stage III NSCLC as well as the emerging role of immunotherapy, and practical clinical considerations for anticipating, mitigating, and managing immune-related adverse events.
CE Concepts

Complying With USP , , and in Iowa for Pharmacists

The Iowa Board of Pharmacy requires full compliance with United States Pharmacopoeia (USP) General Chapters , , and as of December 1, 2019. Compliance with USP is required for both compounding and non-compounding pharmacies (657 IAC 8.5(11)). This activity will assist pharmacists and pharmacy technicians in navigating these requirements.
CEimpact

Magnifying Glass on the Renal Impacts of GLP-1 RA: Current and Future

Target Audience This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes. Learning Objectives Upon completion of this activity, participants should be able to: Review data related to an improved understanding of the impact of GLP-1 RAs on kidney health and other microvascular outcomes (Modules 4 & 5) Enhance patient unde...
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC

Diabetes and Underserved Populations: Emergency Calling for Immediate Action

Target Audience This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes. Learning Objectives Upon completion of this activity, participants should be able to: Describe strategies to enhance access to diabetes care among underserved, high-risk populations, such as African American patients and those in rural or disadvanta...
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC

Putting it All Together for GLP-1 Targeted Agents: One Size Does Not Fit All

Target Audience This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes. Learning Objectives Upon completion of this activity, participants should be able to: Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration r...
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC

Complying With USP , , and in Iowa for Technicians

The Iowa Board of Pharmacy requires full compliance with United States Pharmacopoeia (USP) General Chapters , , and as of December 1, 2019. Compliance with USP is required for both compounding and non-compounding pharmacies (657 IAC 8.5(11)). This activity will assist pharmacists and pharmacy technicians in navigating these requirements.
CEimpact

Magnifying Glass on the CV Properties of GLP-1 RAs

Target Audience This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes. Learning Objectives Upon completion of this activity, participants should be able to: Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration r...
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC

Guidelines and Their Rationale: A 2021 Refresher

Target Audience This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes. Learning Objectives Upon completion of this activity, participants should be able to: Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration r...
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC

Fundamental Compounding with Pharmacy Law

September 8 - 10, 2022 FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law. This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other health care professionals are also welcome to attend. CONTENT This course provides didactic and hands...
American College of Apothecaries

Surviving and Thriving with ADHD: Part 1. Stimulant and Nonstimulant Treatment

There has been an increase in prescription medications, mainly stimulants, for the treatment of attention deficit hyperactivity disorder (ADHD) along with an explosion of new formulations. A 2016 CDC report estimates that about 9% of children 2 to 17 years of age (6.1 million) have been diagnosed with ADHD. Among the children with ADHD, 6 out of 10 were taking ADHD medication. The lifetime prevalence of ADHD has been estimated to be as high as 8.1%. In 2015, 4% of privately insured women ages ...
The Rx Consultant

The Use of Direct Acting Oral Anti-Coagulants in Vulnerable Populations

Recommendations and evidence surrounding the use of DOAC’s in special populations continue to evolve to address concerns of use in patients with obesity, renal disease, active malignancy, and older adults. DOAC’s are a widely prescribed newer class of medications with emerging clinical recommendations and evidence for safe use. Pharmacists have a key role to play as part of the care team in formulating anticoagulation regimens that are appropriate for individual patients, and would benefit...
American Academy of CME

Take Control: Early Use of AADs for Rhythm Control in Atrial Fibrillation

Overview Although guidelines for the treatment of atrial fibrillation (AF) include the goals of preventing thromboembolism and providing rhythm control and rate control, rhythm control strategies remain largely underutilized. Most physicians choose rate control for initial AF management—only considering rhythm control measures when adequate symptom control is not achieved. Additionally, increasing interest in electrophysiological approaches to rhythm control—despite ongoing debate over it...
Jointly provided by Penn State College of Medicine and RedMedEd

Lipids Health Prime Time™: Episode 1 Setting LDL-C Thresholds: Why Lower Is Better, What the Guidelines Say, and The Role of Current Nonstatin Therapies

Target Audience This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs. Program Overview This fast-paced news broadcast will feature expert discussions about implementing guideline recommendations for optimizing statin and non-statin therapy for the lowering of low-density lipoprotein cholesterol (LDL-C). Learning Objectiv...
National Lipid Association. Paradigm Medical Communications, LLC is the educational partner

1,800 Seconds™ in Vaccines and MS Treatment

Target Audience This activity is designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS. Program Overview This 30-minute (1,800 seconds) activity will provide an overview of evidence related to vaccinations in people with MS on disease-modifying therapy, including some of the latest data and guidance related to COVID-19 vaccines. Learning Objectives Upon c...
The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education

Advanced Pharmaceutical Compounding

October 14-15, 2022 ADVANCED PHARMACEUTICAL COMPOUNDING is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, and marketers who want to learn more advanced compounding skills and techniques for the community patient. Both non-sterile and sterile dosage forms will be covered however emphasis will be placed on non-sterile dosage forms. Physicians and other healthcare professionals are welcome to attend. This course is a combination of didactic ...
American College of Apothecaries

Part 1: Understanding the Fundamentals of Pain

Target Audience This activity is designed specifically for primary care clinicians, registered nurses, advanced practice registered nurses, pharmacists, and other members of the healthcare team. Program Overview Pain is a pervasive problem in the United States that poses many challenges to clinicians and patients. The potential for opioid misuse, abuse, and addiction contributes to the complexity of appropriate pain management. This CME/CE activity, which is Part 1 of a three-part series ...
Postgraduate Institute for Medicine and Talem MedEd

Part 2: Best Practices for Prescribing Opioids in Primary Care

Target Audience This activity is designed specifically for primary care clinicians, registered nurses, advanced practice registered nurses, pharmacists, and other members of the healthcare team. Program Overview While prescription opioid use continues to decline rapidly, opioid dispensing remains high in certain areas of the US, increasing the potential for opioid misuse, abuse, and addiction. Efforts to educate clinicians on opioid prescribing and comprehensive pain management remain ess...
Postgraduate Institute for Medicine and Talem MedEd

Part 3: Opioid Risk Evaluation, Mitigation, and Management

Target Audience This activity is designed specifically for primary care clinicians, registered nurses, advanced practice registered nurses, pharmacists, and other members of the healthcare team. Program Overview The opioid epidemic is a national health crisis that results in tens of thousands of opioid-related overdose deaths annually. It is critical that the millions of patients with pain receive appropriate care while mitigating the risks of opioid misuse, abuse, and diversion. This CME...
Postgraduate Institute for Medicine and Talem MedEd

Case by Case: Reviewing Diagnois and Treatment of Chronic Progressive Fibrosing Interstitial Lung Disease Case of Rheumatoid Arthritis Arthritis-Associated Interstitial Lung Disease

Target Audience This activity has been designed to meet the educational needs of pulmonologists, radiologists, and pathologists. It may also be of benefit to primary care physicians, rheumatologists, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other healthcare professionals who care for patients with chronic progressive fibrosing interstitial lung disease (PF-ILD). Program Overview Progressive fibrosing ILD occurring in patients with RA significantly increas...
Paradigm Medical Communications, LLC.

Case by Case: Reviewing Diagnois and Treatment of Chronic Progressive Case of Post-COVID Interstitial Lung Disease

Target Audience This activity has been designed to meet the educational needs of pulmonologists, radiologists, and pathologists. It may also be of benefit to primary care physicians, rheumatologists, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other healthcare professionals who care for patients with chronic progressive fibrosing interstitial lung disease (PF-ILD). Program Overview Patients with lingering ILD symptoms after COVID infection may have a genetic...
Paradigm Medical Communications, LLC.

HIV Pharmacotherapy CE Online Enduring Program - New!

HIV pharmacotherapy is unsurpassed in its complexity when compared with other chronic illnesses, making pharmaceutical care in this area particularly challenging. However, caring for persons infected with HIV is becoming more common as individuals with the disease are living longer and are presenting to a diversity of practice settings. Many pharmacists find themselves uncomfortable with their level of knowledge in the area of HIV either because they did not receive any HIV training in their f...
UB School of Pharmacy

INTERCEPT: IdeNTifying and Managing CancER Treatment CardiotoxicitiEs in Patients Undergoing Therapy

Target Audience This activity is intended for nationally, regionally, and locally based oncology and cardiology physicians, advanced practice nurses, PAs, nurses, pharmacists and other healthcare professionals who are involved in the management of patients undergoing cancer treatment. Program Overview The educational goal of this activity is to provide healthcare professionals with knowledge and strategies to identify areas for improvement in the assessment and management of patients at r...
Duke Cancer Network, Duke Heart Network and Catamount Medical Education

The Hypothyroid Patient

About 12% of the US population has some form of thyroid disease, and more than half of them are unaware of their condition. Hypothyroidism is the most common thyroid condition. It affects about 2% of women and 0.1-0.2% of men; however, in adults over 60 years old, 6% of women and 2.5% of men have the condition. Hypothyroidism is a chronic disease that requires lifelong treatment; fortunately, it can be easily managed with thyroid hormone replacement medication. The recommended treatment is ...
The Rx Consultant

Veterinary Compounding Essentials

October 28 - 29, 2022 VETERINARY COMPOUNDING ESSENTIALS is an accredited 15-hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing. Upon completion of this program, the participant will be able to: • Demonstrate knowledge of...
American College of Apothecaries

DRAVET SYNDROME: TRANSITION FROM PEDIATRIC TO ADULT CARE

Target Audience The educational design of this activity addresses the needs of neurologists, pediatric neurologists, epileptologists, pediatric epileptologists, pediatricians, primary care providers, general practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved and/or interested in the management of patients with DS. Statement of Need/Program Overview The transition of care from a pediatric to an adult setting is an increasingly critical time in th...
Global Education Group and Platform Q Health Education, LLC

Online CE - Reducing Risk of Cardiovascular Disease

Course Objectives At the conclusion of this session, the participant will be able to: Review medications and lifestyle modifications that are recommended for the treatment of hypercholesterolemia. Identify the patient populations that benefit from statin therapy based on evidence from clinical trials. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with dyslipidemia. Define the role and optimal use of nonstatin therapy to lower LDL-C. Ex...
University Learning Systems

Implementing a Shingles Protocol in Pharmacies

Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles vaccination remains low. Community pharmacists play a critical role in educating at-risk patients abou...
CME Outfitters

Considerations for Antimicrobial Selection in Clostridioides difficile Infection

This educational program is designed for infectious disease pharmacists interested in new therapies and clinical trials in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. What happens if the patient returns with recurrence? Watch to find out as the faculty discuss a patie...
ACHL

Cardiovascular Risk Left Behind: An Interactive Exploration of Triglyceride-Rich Remnant Lipoproteins

TARGET AUDIENCE: This curriculum and corresponding interventions are designed for Internists, Primary Care Physicians, Family Medicine, Cardiologists, Endocrinologists, Lipid Specialists, Nurse Practitioners, Advanced Practice Nurses, and/or Physicians Assistants, Pharmacists who are involved in the care and treatment of patients with ASCVD. PROGRAM OVERVIEW: Join us for this 1-hour interactive online activity with an in-clinic reference guide aimed at providing clinicians with a comprehens...
National Lipid Association

17th Annual Emergency Medicine Update: Hot Topics

An in-person highly interactive sessions and small group workshops that focus on learning about current and progressive trends in the practice of emergency medicine. Join other physicians, physician assistants, nurses, nurse practitioners and pharmacists to practice and learn skills for urgent and emergent settings.
UC Davis Health; Department of Emergency Medicine

Fundamental Compounding with Pharmacy Law

November 10 - 12, 2022 FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law. This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other health care professionals are also welcome to attend. CONTENT This course provides didactic and hands...
American College of Apothecaries

COVID-19—Associated Invasive Fungal Infections: Multidisciplinary Management

Target Audience This activity is directed to physicians with specialties in infectious diseases, pulmonary/critical care medicine, and pathology/laboratory medicine as well as other healthcare providers who care for patients with severe COVID-19. Program Overview Patients with severe COVID-19 who require mechanical ventilation are at increased risk for invasive fungal infections (IFIs), including COVID-19–associated pulmonary aspergillosis (CAPA), endemic fungi reactivation and non-Aspe...
Postgraduate Institute for Medicine, Terranova Medica, LLC and the Mycoses Study Group Education & Research ConsortiumC.

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map